New Research Calls for Changes in Lung Cancer Screening Guidelines
A recent study by Northwestern Medicine highlights significant gaps in current lung cancer screening practices, suggesting they may be missing many Americans at risk. The study, published in JAMA Network Open, examined nearly 1,000 lung cancer patients treated at Northwestern between 2018 and 2023 to evaluate who met existing screening guidelines set by the U.S. Preventive Services Task Force (USPSTF).
Currently, the USPSTF recommends yearly CT scans for adults aged 50 to 80 who have a 20 pack-year smoking history, meaning those who smoked one pack a day for 20 years, as well as current smokers or those who quit within the last 15 years. Shockingly, only about 35% of lung cancer patients diagnosed during the study met these screening criteria, meaning roughly two-thirds did not receive early screening.
Dr. Luis Herrera, a thoracic surgeon at Orlando Health, emphasized that these guidelines overlook many individuals, including those who have quit smoking or non-smokers who may also be at risk for lung cancer.
The study pointed out that among those missed by the guidelines, many had adenocarcinoma, the most common type of lung cancer in non-smokers. Additionally, the missed patients were more likely to be women and individuals of Asian descent.
There was a notable difference in survival rates between the two groups. Patients not meeting the screening criteria had a median survival of 9.5 years, compared to 4.4 years for those who did qualify. This difference underlines a critical flaw in the current system that fails to catch various at-risk populations early enough for effective treatment.
Dr. Herrera noted that participation in lung cancer screenings based on smoking history is low, likely due to the complexities of the criteria and the stigma around smoking. The study suggests that a more inclusive approach could save lives.
To explore this, researchers modeled an alternative strategy: offering screenings to everyone aged 40 to 85, regardless of their smoking status. This new approach could potentially identify about 94% of lung cancers in their study group.
They estimate that expanding screening in this way could prevent around 26,000 deaths from lung cancer in the U.S. each year, at an estimated cost of $101,000 per life saved. This is significantly more cost-effective compared to the current screening methods for breast and colorectal cancers.
While lung cancer remains the deadliest cancer in the U.S., with more annual deaths than colon, prostate, and breast cancer combined, the narrow eligibility criteria prevent millions of individuals from being screened. Expanding the guidelines could help close these gaps and lead to earlier detection and treatment for those at risk.
Researchers acknowledged the limitations of the study, which was conducted at a single academic center and may not fully represent the broader population. They also highlighted the importance of considering potential downsides of broader screening, such as false positives.
As the discussion around lung cancer screenings evolves, experts urge patients to explore various evaluation options for lung health, including heart calcium scores, CT scans, and other imaging tests that can assess lung nodules.
Lung cancer screening practices continue to be a critical area for improvement, as new research sheds light on the need for broader, more inclusive approaches that can save lives.
